Avastin Loses Approval For Breast Cancer

The FDA said it is recommending that Roche's Avastin no longer be approved for treatment of breast cancer.

Sections:  living   
Topics:  avastin   breast cancer   cancer   fda   roche's avastin   
RELATED ARTICLES
  • Cancer Physicians Attack High Drug Costs
    More than 100 cancer specialists have banded together to persuade pharmaceutical companies to bring prices down, suggesting that the high prices for medicine needed to keep someone alive is profiteering. More
  • Patients’ Genes Seen as Future of Cancer Care
    Major academic medical centers in New York and around the country are spending and recruiting heavily in what has become an arms race within the war on cancer. The investments are based on the belief that the medical establishment is moving toward the routine sequencing of every patient’s genome in the quest for “precision medicine,” a course for prevention and treatment based on the special, even unique characteristics of the patient’s genes. More
  • Even after melanoma, some people keep on using tanning beds
    You would think that people who were diagnosed with melanoma -- the most deadly form of skin cancer -- would be meticulously careful about using sunscreen, avoiding tanning salons and generally protecting their skin. More
  • Roger Ebert (1942-2013)
    Roger Ebert loved movies. Except for those he hated. For a film with a daring director, a talented cast, a captivating plot or, ideally, all three, there could be no better advocate than Roger Ebert, who passionately celebrated and promoted excellence in film while deflating the awful, the derivative, or the merely mediocre with an observant eye, a sharp wit and a depth of knowledge that delighted his millions of readers and viewers. More
  • Scientists find treatment to kill every kind of cancer tumor
    Researchers might have found the Holy Grail in the war against cancer, a miracle drug that has killed every kind of cancer tumor it has come in contact with, the New York Post reported. The drug works by blocking a protein called CD47 that is essentially a "do not eat" signal to the body's immune system, according to Science Magazine. More
BING NEWS:
  • AbbVie: Stock Will Break $100 Once Management And Market Are On Same Page
    AbbVie stock looked to have strong momentum in July, but Q2 results triggered a slide from $100, to $84 at the the time of writing.
    10/20/2020 - 5:41 pm | View Link
  • Roche's Tecentriq + Avastin Gets Positive CHMP Opinion for HCC
    The CHMP has recommended the approval of the combination for HCC patients who have ... certain types of metastatic urothelial cancer and in PD-L1-positive metastatic triple-negative breast cancer ...
    09/21/2020 - 4:40 am | View Link
  • More

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Living News